Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants
US6790849B2 · kind B2 · utility
14Cited by
5References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 26, 2002 |
| Grant date | Sep 14, 2004 |
| Priority date | — |
| Expiry date | Mar 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the treatment, management, and/or prevention of inflammation, asthma or symptoms thereof, allergic disorders such as allergic rhinitis, and dermatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.